563A irway hyperresponsiveness (AHR) is believed to refl ect infl ammation in the airways that is relatively specifi c for asthma. 1 The diagnostic evaluation for asthma includes measures of AHR, most commonly using methacholine provocation. In children with sickle cell disease (SCD), AHR is present in up to 78% of those tested, 2,3 whereas the prevalence of asthma in children with SCD is 20% to 48%. [4][5][6] Given that AHR is more prevalent than asthma in children with SCD, mechanisms other than asthmarelated infl ammation may be causing this high rate of AHR. Among children with HbSS or sickle cell anemia (SCA), a doctor diagnosis of asthma has been associated with an increased rate of pain, acute chest syndrome, and death. 4,5,7,8 Although these data imply that asthma has a signifi cant disease-modifying effect in children with SCA, characteristics of SCA, such as episodes of acute chest syndrome, 9 pulmonary function abnormalities, 10-12 and chronic respiratory symptoms, add complexity to the diagnosis of asthma. Thus, it is not clear if descriptions of asthma in these children refl ect the presence of two distinct comorbid conditions or an asthma-like phenotype secondary Background: The high prevalence of airway hyperresponsiveness (AHR) among children with sickle cell anemia (SCA) remains unexplained. Methods: To determine the relationship between AHR, features of asthma, and clinical characteristics of SCA, we conducted a multicenter, prospective cohort study of children with SCA. Dose response slope (DRS) was calculated to describe methacholine responsiveness, because 30% of participants did not achieve a 20% decrease in FEV 1 after inhalation of the highest methacholine concentration, 25 mg/mL. Multiple linear regression analysis was done to identify independent predictors of DRS. Results: Methacholine challenge was performed in 99 children with SCA aged 5.6 to 19.9 years (median, 12.8 years). Fifty-four (55%) children had a provocative concentration of methacholine producing a 20% decrease in FEV 1 , 4 mg/mL. In a multivariate analysis, independent associations were found between increased methacholine responsiveness and age ( P , .001), IgE ( P 5 .009), and lactate dehydrogenase (LDH) levels ( P 5 .005). There was no association between methacholine responsiveness and a parent report of a doctor diagnosis of asthma ( P 5 .986). Other characteristics of asthma were not associated with methacholine responsiveness, including positive skin tests to aeroallergens, exhaled nitric oxide, peripheral blood eosinophil count, and pulmonary function measures indicating airfl ow obstruction.